PharmaShots | Incisive News in 3 Shots

Subscribe Now

DeepQure

DeepQure Reports the US FDA’s IDE Approval of HyperQure for Treating Resistant Hypertension

DeepQure Reports the US FDA’s IDE Approval of HyperQure for Treating Resistant Hypertension

June 10, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us